Schroder Investment Management Group
BSTG

Schroder Investment Management Group’s Biostage, Inc. Common Stock BSTG Stock Holding History

Schroder Investment Management Group’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-239
Closed -$1.94K – 1543
2014
Q3 		$1.94K Hold
239
– – ﹤0.01% 1421
2014
Q2 		$2.5K Hold
239
– – ﹤0.01% 1367
2014
Q1 		$2.17K Hold
239
– – ﹤0.01% 1410
2013
Q4 		$1.14K Buy
+239
New +$1.12K ﹤0.01% 1470

Other funds holding BSTG

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Schroder Investment Management Group's BSTG Position: Q4 2014 in Review

Schroder Investment Management Group sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2014, closing a stake of 239 shares — an estimated $1.94K sold.

Schroder Investment Management Group first reported a position in BSTG in Q4 2013 and held it in 4 quarters. The position peaked at $2.5K in Q2 2014. 44 funds tracked by Wall St. Rank hold BSTG as of Q4 2014.

  • Schroder Investment Management Group reported no remaining Biostage, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 239 Biostage, Inc. Common Stock shares in Q4 2014, an estimated $1.94K.
  • Schroder Investment Management Group first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 4 quarters.
  • Schroder Investment Management Group's Biostage, Inc. Common Stock position peaked at $2.5K in Q2 2014.
  • 44 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2014.

Based on Schroder Investment Management Group's 13F filing for Q4 2014, filed 17 Feb 2015.